Bayer Joins Sensyne Health Consortium Working on National Linked Patient Data Capability for Accelerating the Discovery of New Medicines
Sensyne Health plc (LSE: SENS), the British clinical AI technology company, and Bayer, the life sciences company, announce that Bayer has become Sensyne Health's preferred pharmaceutical partner to work together on the development of a national linked patient data capability. Bayer joins Microsoft, EY, JP Morgan, and Peel Hunt in this consortium.
Read more ...
AstraZeneca Starts Artificial Intelligence Collaboration to Accelerate Drug Discovery
AstraZeneca and BenevolentAI began a long-term collaboration to use artificial intelligence (AI) and machine learning for the discovery and development of new treatments for chronic kidney disease (CKD) and idiopathic pulmonary fibrosis (IPF).
Read more ...
Red Hat Helps Public Health England Use Open Source to Pursue Hybrid Cloud Operations
Red Hat, Inc. (NYSE: RHT), the world's leading provider of open source solutions, announced that Public Health England (PHE), an executive agency of the Department of Health and Social Care in the United Kingdom, is using Red Hat's open hybrid cloud technologies to support modern digital public health services in the UK.
Read more ...
Hospital Diagnoses Critically Ill Children Using Artificial Intelligence
The Rady Children’s Hospital (San Diego, USA) used Moon, software developed by the Leuven-based (Belgium) company Diploid. Moon is the first software worldwide to use Artificial Intelligence (AI) for the diagnosis of rare diseases. This new method accelerates the diagnosis of seriously ill children in intensive care and opens the door to the use of genome sequencing as a first-line diagnostic test for babies with unknown disorders.
Read more ...
Derby Starts Drive for Safer and more Informed Electronic Prescribing for Hospital Patients
DXC Technology (NYSE: DXC) is collaborating with Royal Derby Hospital, part of the University Hospitals of Derby and Burton NHS Foundation Trust, on an initiative that will better alert doctors to genuine prescribing dangers, electronically link patient information and best practice to prescribing decisions, and improve patient safety whilst reducing pressure on staff.
Read more ...
CardioSecur® Knows the History of your Heart
Cardiovascular diseases are still one of the most common causes of death worldwide, that is why today it is more important than ever to know about one's heart. The ideal method for detecting heart events is to perform ECG readings at regular intervals.
Read more ...
Patients Given Unprecedented Access to X-Rays, Ultrasound and other Imaging
A network that connects every NHS acute hospital in England is giving thousands of patients unprecedented and easy online access to everything from their x-rays through to ultrasound, CT and MRI scans, and a great deal more.
Read more ...
Sensyne Health plc (LSE: SENS), the British clinical AI technology company, and Bayer, the life sciences company, announce that Bayer has become Sensyne Health's preferred pharmaceutical partner to work together on the development of a national linked patient data capability. Bayer joins Microsoft, EY, JP Morgan, and Peel Hunt in this consortium. 
AstraZeneca and BenevolentAI began a long-term collaboration to use artificial intelligence (AI) and machine learning for the discovery and development of new treatments for chronic kidney disease (CKD) and idiopathic pulmonary fibrosis (IPF). 
Red Hat, Inc. (NYSE: RHT), the world's leading provider of open source solutions, announced that Public Health England (PHE), an executive agency of the Department of Health and Social Care in the United Kingdom, is using Red Hat's open hybrid cloud technologies to support modern digital public health services in the UK. 
The Rady Children’s Hospital (San Diego, USA) used Moon, software developed by the Leuven-based (Belgium) company Diploid. Moon is the first software worldwide to use Artificial Intelligence (AI) for the diagnosis of rare diseases. This new method accelerates the diagnosis of seriously ill children in intensive care and opens the door to the use of genome sequencing as a first-line diagnostic test for babies with unknown disorders. 
DXC Technology (NYSE: DXC) is collaborating with Royal Derby Hospital, part of the University Hospitals of Derby and Burton NHS Foundation Trust, on an initiative that will better alert doctors to genuine prescribing dangers, electronically link patient information and best practice to prescribing decisions, and improve patient safety whilst reducing pressure on staff. 
Cardiovascular diseases are still one of the most common causes of death worldwide, that is why today it is more important than ever to know about one's heart. The ideal method for detecting heart events is to perform ECG readings at regular intervals. 
A network that connects every NHS acute hospital in England is giving thousands of patients unprecedented and easy online access to everything from their x-rays through to ultrasound, CT and MRI scans, and a great deal more.